FDA.reportPublic FDA data

benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution

RxCUI
1362704
RxNorm name
benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
Display name
Benzocaine/Cetylpyridinium/Menthol (Mucosal)
Full name
benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
Term type
SCD
Status
Active
Strength
2-0.1-0.5%
Dose form
Sol
Route
Mucosal
Updated
2026-07-24 06:53:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012013
Active start
012013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine20 MG / 1 MLbenzocainebenzocaine
cetylpyridinium chloride1 MG / 1 MLcetylpyridiniumcetylpyridinium chloride
menthol5 MG / 1 MLmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Mucous Membrane Topical Solution316956

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
cetylpyridinium2286
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbenzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical SolutionNAMES
RxNorm Namebenzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical SolutionNAMES
RxNorm Synonymbenzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical SolutionNAMES
TTYSCDATTRIBUTES
RxCUI1362704CODES
MMSL_CODECD27957CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
63102010601rxnav_ndcsyes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ed70911b-9da8-4e1d-97fa-66b18d28516abenzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical SolutionPSN6Llorens- Orasep Liquid 50320251231
ed70911b-9da8-4e1d-97fa-66b18d28516abenzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical SolutionSY6Llorens- Orasep Liquid 50320251231
ed70911b-9da8-4e1d-97fa-66b18d28516abenzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical SolutionSCD6Llorens- Orasep Liquid 50320251231

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCB05CAAntiinfectivesATC1-4cetylpyridinium
ATCR02AAAntisepticsATC1-4cetylpyridinium
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
ATCD09AAMedicated dressings with antiinfectivesATC1-4cetylpyridinium
ATCD08AJQuaternary ammonium compoundsATC1-4cetylpyridinium
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD002594CetylpyridiniumCHEMhas_ingredientcetylpyridinium chloride
MEDRTD002594CetylpyridiniumCHEMhas_ingredientcetylpyridinium
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD003773Dental PlaqueDISEASEmay_preventcetylpyridinium chloride
MEDRTD003773Dental PlaqueDISEASEmay_preventcetylpyridinium
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH20 MG/ML / 1 MG/ML / 5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODECD27957
CODESRxCUI1362704
NAMESPrescribable Synonymbenzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution
NAMESRXNAV_STRbenzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
NAMESRxNorm Namebenzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
NAMESRxNorm Synonymbenzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary